{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT03988439",
            "orgStudyIdInfo": {
                "id": "V01-118A-401"
            },
            "organization": {
                "fullName": "Bausch Health Americas, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Safety and Pharmacokinetics Study of IDP-118 Lotion in Pediatric Participants With Plaque Psoriasis",
            "officialTitle": "A Phase 4, Open-Label, Multicenter Study Evaluating the Absorption and Systemic Pharmacokinetics and HPA Axis Suppression Potential of Topically Applied IDP-118 Lotion in Pediatric Subjects With Moderate to Severe Plaque Psoriasis",
            "therapeuticArea": [
                "Dermatology"
            ],
            "study": "a-safety-and-pharmacokinetics-study-of-idp-lotion-in-pediatric-participants-with-plaque-psoriasis"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2021-03-24",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-06",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-06",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2019-06-13",
            "studyFirstSubmitQcDate": "2019-06-13",
            "studyFirstPostDateStruct": {
                "date": "2019-06-17",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-07-25",
            "lastUpdatePostDateStruct": {
                "date": "2023-07-27",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Bausch Health Americas, Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This study is to evaluate the safety, the systemic exposure, and the hypothalamic-pituitary-adrenal (HPA) axis suppression potential for topically applied IDP-118 lotion in pediatric participants with moderate to severe plaque psoriasis."
        },
        "conditionsModule": {
            "conditions": [
                "Psoriasis"
            ],
            "keywords": [
                "Plaque psoriasis"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE4"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 45,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "IDP-118 Lotion",
                    "type": "EXPERIMENTAL",
                    "description": "Two cohorts of pediatric participants (1 cohort of participants age 12 to 16 years 11 months and 1 cohort of participants age 4 to 11 years 11 months) will apply IDP-118 Lotion to Investigator identified lesions affecting a minimum of 10% body surface area (BSA) once daily for 8 weeks.",
                    "interventionNames": [
                        "Drug: IDP-118 Lotion"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "IDP-118 Lotion",
                    "description": "Topical",
                    "armGroupLabels": [
                        "IDP-118 Lotion"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Pharmacokinetics: : Maximum Observed Drug (Halobetasol Propionate, Tazarotene, or Tazarotenic Acid) Concentration in Plasma (Cmax) of IDP-118 Lotion Analytes",
                    "description": "On Days 28-29, blood samples will be collected from each participant for the determination of plasma concentrations and PK parameters of IDP-118 lotion analytes.",
                    "timeFrame": "0 (predose), 1, 2, 4, 8, 12, and 24 hours postdose"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Proportion of Participants With Hypothalamic-Pituitary-Adrenal (HPA) Axis Suppression at Week 8",
                    "description": "An HPA axis suppression is defined as a 30 minute poststimulation cortisol level of \u226418 micrograms/deciliter (\u03bcg/dL) at the end of the study.",
                    "timeFrame": "Week 8"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Is 4 to 16 years 11 months of age at time of informed consent/assent obtained.\n* Verbal and written informed consent/assent obtained from the participant and/or parent or legal guardian.\n* Has a clinical diagnosis of psoriasis at Screening and Baseline with an Investigator's Global Assessment (IGA) score of 3 or 4. The face, scalp, axillae, and intertriginous areas are to be excluded in this assessment, if psoriasis is present.\n* Has an area of plaque psoriasis appropriate for topical treatment that involves a BSA of at least 10% at Screening and Baseline. The face, scalp, axillae, and intertriginous areas are to be excluded in this calculation.\n* Is willing and able to avoid prolonged exposure of the treatment area to ultraviolet radiation (natural and artificial) for the duration of the study.\n* Is in good general adrenal health, as determined by a 30-minute postcosyntropin stimulation serum cortisol level that is \\>18 \u03bcg/dL at the Screening visit.\n* Females of childbearing potential and females who are pre-menses (9 years and older) must be willing to practice effective contraception for the duration of the study.\n\nExclusion Criteria:\n\n* Has a history of adrenal disease.\n* Presents with any concurrent skin condition that could interfere with the evaluation of the treatment areas, as determined by the Investigator.\n* Is pregnant, nursing an infant, or planning a pregnancy during the study period.\n* Has received treatment with any investigational drug or device within 60 days or 5 drug half-lives (whichever is longer) prior to baseline or is concurrently participating in another clinical study with an investigational drug or device.\n* Received treatment with a topical antipsoriatic drug product other than corticosteroids within 14 days prior to the Baseline visit and/or treatment containing corticosteroids within 28 days prior to the screening HPA axis stimulation test.\n* Has a history of hypersensitivity or allergic reaction to any of the study drug constituents.\n* Is considered by the Investigator, for any other reason, to be an unsuitable candidate for the study.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "4 Years",
            "maximumAge": "17 Years",
            "stdAges": [
                "CHILD"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Alison Magnotti-Nagel",
                    "role": "CONTACT",
                    "phone": "19085418664",
                    "email": "alison.magnotti-nagel@bauschhealth.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Varsha Bhatt",
                    "affiliation": "Bausch Health Americas, Inc.",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Bausch Site 7",
                    "status": "RECRUITING",
                    "city": "Doral",
                    "state": "Florida",
                    "zip": "33166",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 25.81954,
                        "lon": -80.35533
                    }
                },
                {
                    "facility": "Bausch Site 8",
                    "status": "RECRUITING",
                    "city": "Miami",
                    "state": "Florida",
                    "zip": "33173",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 25.77427,
                        "lon": -80.19366
                    }
                },
                {
                    "facility": "Bausch Site 3",
                    "status": "RECRUITING",
                    "city": "Louisville",
                    "state": "Kentucky",
                    "zip": "40217",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 38.25424,
                        "lon": -85.75941
                    }
                },
                {
                    "facility": "Bausch Site 6",
                    "status": "RECRUITING",
                    "city": "Saint Joseph",
                    "state": "Missouri",
                    "zip": "64506",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.76861,
                        "lon": -94.84663
                    }
                },
                {
                    "facility": "Bausch Site 1",
                    "status": "TERMINATED",
                    "city": "Henderson",
                    "state": "Nevada",
                    "zip": "89052",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 36.0397,
                        "lon": -114.98194
                    }
                },
                {
                    "facility": "Bausch Site 11",
                    "status": "RECRUITING",
                    "city": "Mayfield Heights",
                    "state": "Ohio",
                    "zip": "44124",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 41.51922,
                        "lon": -81.4579
                    }
                },
                {
                    "facility": "Bausch Site 5",
                    "status": "TERMINATED",
                    "city": "San Antonio",
                    "state": "Texas",
                    "zip": "78213",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 29.42412,
                        "lon": -98.49363
                    }
                },
                {
                    "facility": "Bausch Site 4",
                    "status": "RECRUITING",
                    "city": "Murray",
                    "state": "Utah",
                    "zip": "84123",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.66689,
                        "lon": -111.88799
                    }
                },
                {
                    "facility": "Bausch Site 2",
                    "status": "RECRUITING",
                    "city": "Panama City",
                    "country": "Panama",
                    "geoPoint": {
                        "lat": 8.9936,
                        "lon": -79.51973
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000011565",
                    "term": "Psoriasis"
                }
            ],
            "ancestors": [
                {
                    "id": "D000017444",
                    "term": "Skin Diseases, Papulosquamous"
                },
                {
                    "id": "D000012871",
                    "term": "Skin Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M14422",
                    "name": "Psoriasis",
                    "asFound": "Psoriasis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M15674",
                    "name": "Skin Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M19713",
                    "name": "Skin Diseases, Papulosquamous",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        }
    },
    "hasResults": false
}